Compositions of placentally-derived stem cells for the treatment of cancer

Inactive Publication Date: 2007-02-22
MEDISTEM
View PDF2 Cites 102 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The use of cellular differentiation therapy has been previous attempted in cancer patients; however, the majority of such differentiation inducers have been synthetic chemicals administered at unnaturally high doses.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compositions of placentally-derived stem cells for the treatment of cancer
  • Compositions of placentally-derived stem cells for the treatment of cancer
  • Compositions of placentally-derived stem cells for the treatment of cancer

Examples

Experimental program
Comparison scheme
Effect test

examples

[0052] The following examples are offered to illustrate, but not to limit, the claimed invention.

1. CD34+ Cell Purification

[0053] Cord blood was obtained from consenting mothers undergoing cesarean delivery of healthy, full-term infants, and low-density (less than 1.077 g / ml) cells were isolated by centrifugation on Ficoll-Hypaque. CD34+ cell-enriched populations (65-98% CD34+ cells) were obtained by removal of lineage marker-positive cells using a column (n=2); and positive (EasySep) selection using magnetic beads (n=1; StemCell Technologies Inc.). Cells were stimulated overnight for in vivo experiments and for 48 hours for in vitro experiments at densities less than or equal to 2×105 cells / ml in Iscove's medium supplemented with 1% BSA, 10 μg / ml bovine pancreatic insulin, and 200 μg / ml human transferrin (BIT; StemCell Technologies Inc.), 10−4 mol 2-mercaptoethanol, 2 mM glutamine, 100 ng / ml FL (Immunex Corp.), 100 ng / ml SF, 50 ng / ml Tpo (Genentech Inc.), and 100 ng / ml hIL-6 (pro...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
densityaaaaaaaaaa
molecular weightaaaaaaaaaa
molecular weightaaaaaaaaaa
Login to view more

Abstract

Disclosed are preparations of placentally-derived stem cells and compositions useful for the treatment of cancer. Said stem cells and compositions function through inducing a “guided differentiation” program in cancer cells, thereby reducing malignancy. Further extension of the invention pertains to augmenting ability of administered cells to induce differentiation through the co-administration of known differentiation inducing agents. Within the context of this disclosure, methods for inducing host responses to cancer are also described.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS [0001] This application claims priority under 35 U.S.C. §119 to U.S. Provisional Application No. 60 / 699,579, which was filed on Jul. 14, 2005, the disclosure of which is hereby incorporated by reference in its entirety.BACKGROUND [0002] 1. Field of the Invention [0003] The invention disclosed relates generally to the fields of cancer therapy. More particularly, it relates to the process of cancer cell differentiation into cells of reduced malignancy, or lacking of malignancy. More specifically, the invention pertains to the utilization of cord-blood and placentally derived stem cells for the stimulation of cancer cell differentiation. [0004] 2. Description of Related Art [0005] In the field of cellular biology, the definition of “stem cell” is dependent on function more than on morphology. The characteristic function of a stem cell is the ability to both self-renew and to differentiate. Stem cells differentiate upon need of the host in respons...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K35/14C12N5/08A61K35/44A61K35/50C12N5/073
CPCA61K35/44A61K35/50C12N5/0605C12N5/0694A61P35/00A61P35/04
Inventor ICHIM, THOMAS E.
Owner MEDISTEM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap